157 related articles for article (PubMed ID: 15840503)
1. In vivo bioluminescence imaging to evaluate estrogenic activities of endocrine disrupters.
Pillon A; Servant N; Vignon F; Balaguer P; Nicolas JC
Anal Biochem; 2005 May; 340(2):295-302. PubMed ID: 15840503
[TBL] [Abstract][Full Text] [Related]
2. Development and characterization of a cell line that stably expresses an estrogen-responsive luciferase reporter for the detection of estrogen receptor agonist and antagonists.
Wilson VS; Bobseine K; Gray LE
Toxicol Sci; 2004 Sep; 81(1):69-77. PubMed ID: 15166400
[TBL] [Abstract][Full Text] [Related]
3. Recombinant cell bioassays for endocrine disruptors: development of a stably transfected human ovarian cell line for the detection of estrogenic and anti-estrogenic chemicals.
Rogers JM; Denison MS
In Vitr Mol Toxicol; 2000; 13(1):67-82. PubMed ID: 10900408
[TBL] [Abstract][Full Text] [Related]
4. Screening for estrogenicity and anti-estrogenicity: a critical evaluation of an MVLN cell-based transactivation assay.
Freyberger A; Schmuck G
Toxicol Lett; 2005 Jan; 155(1):1-13. PubMed ID: 15585354
[TBL] [Abstract][Full Text] [Related]
5. Dehydroepiandrosterone sulfate estrogenic action at its physiological plasma concentration in human breast cancer cell lines.
Le Bail JC; Allen K; Nicolas JC; Habrioux G
Anticancer Res; 1998; 18(3A):1683-8. PubMed ID: 9673390
[TBL] [Abstract][Full Text] [Related]
6. Construction and validation of improved triple fusion reporter gene vectors for molecular imaging of living subjects.
Ray P; Tsien R; Gambhir SS
Cancer Res; 2007 Apr; 67(7):3085-93. PubMed ID: 17409415
[TBL] [Abstract][Full Text] [Related]
7. Comparison of in vitro and in vivo screening models for androgenic and estrogenic activities.
Sonneveld E; Riteco JA; Jansen HJ; Pieterse B; Brouwer A; Schoonen WG; van der Burg B
Toxicol Sci; 2006 Jan; 89(1):173-87. PubMed ID: 16221957
[TBL] [Abstract][Full Text] [Related]
8. Bioluminescent human breast cancer cell lines that permit rapid and sensitive in vivo detection of mammary tumors and multiple metastases in immune deficient mice.
Jenkins DE; Hornig YS; Oei Y; Dusich J; Purchio T
Breast Cancer Res; 2005; 7(4):R444-54. PubMed ID: 15987449
[TBL] [Abstract][Full Text] [Related]
9. Continuous delivery of D-luciferin by implanted micro-osmotic pumps enables true real-time bioluminescence imaging of luciferase activity in vivo.
Gross S; Abraham U; Prior JL; Herzog ED; Piwnica-Worms D
Mol Imaging; 2007; 6(2):121-30. PubMed ID: 17445506
[TBL] [Abstract][Full Text] [Related]
10. 4-Alkylphenols and related chemicals show similar effect on the function of human and rat estrogen receptor alpha in reporter gene assay.
Sun H; Xu XL; Qu JH; Hong X; Wang YB; Xu LC; Wang XR
Chemosphere; 2008 Mar; 71(3):582-8. PubMed ID: 18028983
[TBL] [Abstract][Full Text] [Related]
11. Development of a stable dual cell-line GFP expression system to study estrogenic endocrine disruptors.
Xu H; Kraus WL; Shuler ML
Biotechnol Bioeng; 2008 Dec; 101(6):1276-87. PubMed ID: 18980187
[TBL] [Abstract][Full Text] [Related]
12. [Bioluminescent imaging: applications to cancerology and endocrinology].
Pillon A; Gauthier P; Balaguer P; Pélegrin A; Nicolas JC
J Soc Biol; 2004; 198(2):157-61. PubMed ID: 15368967
[TBL] [Abstract][Full Text] [Related]
13. Stable luciferase transfected cells for studying steroid receptor biological activity.
Gagne D; Balaguer P; Demirpence E; Chabret C; Trousse F; Nicolas JC; Pons M
J Biolumin Chemilumin; 1994; 9(3):201-9. PubMed ID: 7942125
[TBL] [Abstract][Full Text] [Related]
14. Potential use of an estrogen-glucocorticoid receptor chimera as a drug screen for tissue selective estrogenic activity.
Maru BS; Tobias JH; Rivers C; Caunt CJ; Norman MR; McArdle CA
Bone; 2009 Jan; 44(1):102-12. PubMed ID: 18976723
[TBL] [Abstract][Full Text] [Related]
15. Photoactivable bioluminescent probes for imaging luciferase activity.
Shao Q; Jiang T; Ren G; Cheng Z; Xing B
Chem Commun (Camb); 2009 Jul; (27):4028-30. PubMed ID: 19568622
[TBL] [Abstract][Full Text] [Related]
16. Bioluminescence: imaging modality for in vitro and in vivo gene expression.
Sadikot RT; Blackwell TS
Methods Mol Biol; 2008; 477():383-94. PubMed ID: 19082962
[TBL] [Abstract][Full Text] [Related]
17. A dietary supplement for female sexual dysfunction, Avlimil, stimulates the growth of estrogen-dependent breast tumors (MCF-7) implanted in ovariectomized athymic nude mice.
Ju YH; Doerge DR; Helferich WG
Food Chem Toxicol; 2008 Jan; 46(1):310-20. PubMed ID: 17919800
[TBL] [Abstract][Full Text] [Related]
18. Optimization and prevalidation of the in vitro ERalpha CALUX method to test estrogenic and antiestrogenic activity of compounds.
van der Burg B; Winter R; Weimer M; Berckmans P; Suzuki G; Gijsbers L; Jonas A; van der Linden S; Witters H; Aarts J; Legler J; Kopp-Schneider A; Bremer S
Reprod Toxicol; 2010 Aug; 30(1):73-80. PubMed ID: 20435135
[TBL] [Abstract][Full Text] [Related]
19. Chimeric receptors as a tool for luminescent measurement of biological activities of steroid hormones.
Jausons-Loffreda N; Balaguer P; Roux S; Fuentes M; Pons M; Nicolas JC; Gelmini S; Pazzagli M
J Biolumin Chemilumin; 1994; 9(3):217-21. PubMed ID: 7942127
[TBL] [Abstract][Full Text] [Related]
20. Final amended report on the safety assessment of Methylparaben, Ethylparaben, Propylparaben, Isopropylparaben, Butylparaben, Isobutylparaben, and Benzylparaben as used in cosmetic products.
Int J Toxicol; 2008; 27 Suppl 4():1-82. PubMed ID: 19101832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
